Similar articles

• Apixaban or enoxaparin for thromboprophylaxis.

  Gómez-Outes A, Suárez-Gea ML, Pozo-Hernández C. Gómez-Outes A, et al. N Engl J Med. 2009 Nov 19;361(21):2100-1; author reply 2101. doi: 10.1056/NEJMc091817. N Engl J Med. 2009. PMID: 19923583 No abstract available.
• Apixaban versus enoxaparin for thromboprophylaxis after knee replacement (ADVANCE-2): a randomised double-blind trial.

  Lassen MR, Raskob GE, Gallus A, Pineo G, Chen D, Hornick P; ADVANCE-2 investigators. Lassen MR, et al. Lancet. 2010 Mar 6;375(9717):807-15. doi: 10.1016/S0140-6736(09)62125-5. Lancet. 2010. PMID: 20206776 Clinical Trial.
• Apixaban versus enoxaparin in patients with total knee arthroplasty. A meta-analysis of randomised trials.

  Huang J, Cao Y, Liao C, Wu L, Gao F. Huang J, et al. Thromb Haemost. 2011 Feb;105(2):245-53. doi: 10.1160/TH10-08-0552. Epub 2010 Oct 12. Thromb Haemost. 2011. PMID: 20941455
• Apixaban versus enoxaparin in elective major orthopedic surgery: a clinical review.

  Maniscalco P, Caforio M, Imberti D, Porcellini G, Benedetti R. Maniscalco P, et al. Clin Appl Thromb Hemost. 2015 Mar;21(2):115-9. doi: 10.1177/1076029614546328. Epub 2014 Aug 13. Clin Appl Thromb Hemost. 2015. PMID: 25125051 Review.
• Practical use of apixaban in the prevention of venous thromboembolism after total knee or hip replacement.

  Lassen MR. Lassen MR. Drugs Today (Barc). 2012 Apr;48(4):249-58. doi: 10.1358/dot.2012.48.4.1738052. Drugs Today (Barc). 2012. PMID: 22536567 Review.